Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 176 active Chronic Lymphocytic Leukemia trials
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
Study Type: Interventional Phase 1
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 1
A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
Study Type: Interventional Phase 1
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Study Type: Interventional Phase 2
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
Study Type: Interventional Phase 1
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators’ Expression
Study Type: Interventional Phase 3
Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Study Type: Interventional Phase 1
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
Study Type: Interventional Phase 3
There are 176 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now